Selective media for isolation of Brucella abortus strain RB51

Veterinary Microbiology

Volumn 73, Issue 1, 2000, Pages 51-60

  Hornsby, Richard L ^a   Jensen, Allen E ^a   Olsen, Steven C ^a   Thoen, Charles O ^b  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Brucella abortus; Cattle bacteria; RB51; Selective media; Vaccination

Indexed keywords

AGAR; ANTIBIOTIC AGENT; AZITHROMYCIN; AZLOCILLIN; AZTREONAM; BACITRACIN; BRILLIANT GREEN; CEFALOTIN; CEFIXIME; CEFOPERAZONE; CEFOTAXIME; CINOXACIN; CLINDAMYCIN; COLISTIN; ERYTHROMYCIN; KANAMYCIN; LINCOMYCIN; MALACHITE GREEN; NALIDIXIC ACID; NITROFURANTOIN; NOVOBIOCIN; NYSTATIN; PENICILLIN G; PIPERACILLIN; POLYMYXIN; POLYMYXIN B; RIFAMPICIN; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN;

ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATION; BRUCELLA ABORTUS; CONTROLLED STUDY; CULTURE MEDIUM; NONHUMAN; SERUM;

ANIMALS; BACTERIAL VACCINES; BISON; BRUCELLA ABORTUS; BRUCELLOSIS; COLONY COUNT, MICROBIAL; CULTURE MEDIA; DRUG RESISTANCE, MICROBIAL; FEMALE; MICROBIAL SENSITIVITY TESTS; VACCINATION;

BISON; BOS TAURUS; BOVINAE; BRUCELLA; BRUCELLA MELITENSIS BIOVAR ABORTUS; NEGIBACTERIA; SIPROETA STELENES;

EID: 0034603814     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(00)00149-8     Document Type: Article

References (22)

1. Alton, G.G., Jones, L.M., Angus, R.D., Verger, J.M., 1988. Techniques for the Brucellosis Laboratory. Institut National de la Recherche Agronomique, Paris, France, pp. 17-136.
2. Baskin Y. Study shows one-fifth of female bison infected. Science. 276:1997;1786.
3. Braun W., Bonestell A.E. Independent variations of characteristics in Brucella abortus variants and their detection. Am. J. Vet. Res. 8:1947;386-390.
4. Brown G.M., Ranger C.R., Kelley D.J. Selective media for the isolation of Brucella ovis. Cornell Vet. 61:1971;265-280.
5. Cheville N.F., Stevens M.G., Jensen A.E., Tatum F.M., Halling S.M. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus. Am. J. Vet. Res. 54:1993;1591-1597.
6. Cheville N.F., Olsen S.C., Jensen A.E., Stevens M.G., Palmer M.V., Florance A.M. Effects of age at vaccination on efficacy of Brucella abortus strain RB51 to protect cattle against brucellosis. Am. J. Vet. Res. 57:1996;1153-1156.
7. Crawford, R.P., Adams, L.G., Williams, J.D., Dietrich, R.A., 1990. Economic losses attributable to brucellosis. In: Adams, L.G. (Eds), Advances in Brucellosis Research. Texas A & M University Press, College Station, TX, pp. 357-372.
8. Ewalt, D.R., 1983. A new selective medium for isolating Brucella sp. from bovine milk. Master of Science Thesis. Iowa State University, Ames, IA.
9. Farrell I.D. The development of a new selective medium for the isolation of Brucella abortus from contaminated sources. Res. Vet. Sci. 16:1974;280-286.
10. Keness J., Friedrich I., Banai M., Schonfeld S. Brucella melitensis growth on Loewenstein-Jensen egg medium from a case of Brucella meningitis. Diagn. Microbiol. Infect. Dis. 17:1993;271-273.
11. Kuzdas C.D., Morse E.V. A selective medium for the isolation of brucellae from contaminated materials. J. Bacteriol. 66:1953;502-504.
12. Martínez De Tejada G., Pizarro-Cerdá J., Moreno E., Moriyón I. The outer membranes of Brucella spp. are resistant to cationic peptides. Infect. Immun. 63:1995;3054-3061.
13. Moriyon I., Berman D.T. Effects of nonionic, ionic and dipolar ionic detergents and EDTA on the Brucella cell envelope. J. Bacteriol. 152:1982;822-828.
14. National Committee on Clinical Laboratory Standards. 1993a. Performance Standards For Antimicrobial Disk Susceptibility Tests, 5th Edition. NCCLS, Villanova, PA, pp. 6-10 and 16-20.
15. National Committee on Clinical Laboratory Standards. 1993b. Methods For Dilution Antimicrobial Susceptibility Tests For Bacteria That Grow Aerobically; Approved Standard, 3rd Edition. NCCLS, Villanova, PA, pp 2-4, 13-15 and 19-24.
16. Nettles V.F. Reemerging and emerging infectious diseases: economic and other impacts on wildlife. Am. Soc. Microbiol. News. 62:1996;589-591.
17. Olsen S.C., Jensen A.E., Palmer M.V., Stevens M.G. Evaluation of serologic responses, lymphocyte proliferative responses, and clearance from lymphatic organs after vaccination of bison with Brucella abortus strain RB51. Am. J. Vet. Res. 59:1998;410-415.
18. Roffe T.J., Olsen S.C., Gidlewski T., Jensen A.E., Plamer M.V., Huber R. Biosafety of parenteral Brucella abortus RB51 vaccine in bison calves. J. Wildlife Mgt. 63:1999;950-955.
19. Schurig G.G., Roop R.M., Bagchi T., Boyle S., Buhrman D., Sriranganathan N. Biologic properties of RB51; a stable rough strain of Brucella abortus. Vet. Microbiol. 28:1991;171-188.
20. Stauffer B., Reppert J., Van Metre D., Fingland R., Kennedy G., Hansen G., Pezzino G., Olsen S., Ewalt D. Human exposure to Brucella abortus strain RB51-Kansas, 1997. Morbidity and Mortality Weekly Report. 47:1998;172-175.
21. Stevens M.G., Hennager S.G., Olsen S.C., Cheville N.F. Serologic responses in diagnostic tests for brucellosis in cattle vaccinated with Brucella abortus 19 or RB51. J. Clin. Microbiol. 32:1994;1065-1066.
22. Van Metre D.C., Kennedy G.A., Olsen S.C., Hansen G.R., Ewalt D.R. Brucellosis induced by RB51 vaccine in a pregnant heifer. J. Am. Vet. Med. Assoc. 215:1999;1491-1493.